The Children's Mercy Hospital
Blood and Marrow Transplant Program
2401 Gillham Road
Kansas City, MO 64118
Direct phone: (816) 302-6808
Toll-free: (800) 236-1713
Total transplants by cell source
- Marrow: 24
- PBSC: 8
- Cord Blood: 5
- Autologous (PBSC or Marrow): 33
About the center
The Children's Mercy Hospital's Blood and Bone Marrow Transplant Program treats children and young adults utilizing all donor sources. The program performs transplants for patients with a variety of childhood cancers including leukemia, lymphoma, neuroblastoma, and other solid cancers. The program is focused on novel less toxic transplant approaches to treat patients with non-malignant diseases, such as severe combined immunodeficiency (SCID), aplastic anemia, thalassemia, sickle cell disease, neurometabolic diseases, and other rare genetic disorders.
This center has been performing allogeneic transplants since 1995 and has been an NMDP/Be The Match transplant center since February 2007.
Pediatric - Ibrahim Ahmed, Erin M. Hall, G. Doug Myers
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Ronald McDonald housing is available on the Children's Mercy Hospital campus. Hotel accommodations are also available within close proximity to the hospital. The Hem/Onc/BMT division offers a parent to parent program to connect parents with similar experiences for support. We also offer special child life events. Meditation and religious services are also available.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 48 patients.
The actual 1-year survival of these patients is 89.4%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 72.7% and 92.6%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)